Merck’s antiviral shows promise, the global death toll hits a grim milestone, and researchers look at universal coronavirus vaccines— Tech in Two
Catch up on the most important news today in 2 minutes or less. Get even more news you can use with the Tech in Two newsletter. Sign up here: https://www.wired.com/tt
Load Podcast Series Published: 1635837066